| Important Dates | |
| Opportunity Launched: | October 2005 |
| Content Last Updated: | April 24, 2006 (Description of Partners) |
| December 15, 2005 | Letter of Intent Deadline - Letter of Intent must be courier stamped by this date. |
| February 15, 2006 | Letter of Intent Decision |
| May 1, 2006 | Full applications must be courier stamped by this date. |
| August 31, 2006 | Anticipated notification of decision. |
| October 2, 2006 | Anticipated start date. |
| Summary | |
|
The purpose of this initiative is to support teams of researchers and decision-makers interested in conducting applied health research useful to health system managers and/or policy makers over the next two-to-five years. More specifically, successful applicant teams will conduct health services, systems and policy research projects of up to three years in length, in thematic areas identified as high priority in national consultations conducted by the Canadian Institutes of Health Research (CIHR) - Institute of Health Services and Policy Research (IHSPR), the Canadian Health Services Research Foundation (CHSRF) and partners. Funds Available: The maximum CIHR contribution to each project is $150,000 over the life of the project (up to a maximum of 3 years). Applicants are required to find matching funding (though a 1:1 funding ratio is the acceptable minimum, there is no limit on partner contributions that can be applied to a project). The minimum amount available from CIHR for this program is approximately $3 million of which up to $500,000 is available to researchers undertaking projects of research in the provinces of Newfoundland, Nova Scotia, New Brunswick, Prince Edward Island, Manitoba and Saskatchewan. This provincial partnership initiative is intended to expand the pool of available funds and thereby increase health research activity in these provinces. Researchers in the provinces identified above will be required to secure only 1/3 of the total cost of the project (e.g. up to $100,000 out of $300,000 over the life of the project) from their partners. For these provinces, please note that applicants submitting an application to PHSI may not, in addition, apply to the CIHR Regional Partnership Program; such applications will not be reviewed. | |
Background
Partners
Objectives and Relevant Research Areas
Eligible Research Areas
Eligibility
Funding
Allowable Costs
Merit Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
Communications Requirements
Monitoring, Performance Measurement and Evaluation
How to Apply
Contact Information
Description of Partners
Canadians care about their health and that of their families, friends and communities, and they take great pride in their health care system. Canadians have come to expect convenient access to high quality health services based on need. Recent surveys of Canadians suggest that their overall confidence in the health care system continues to erode, but that they are ready for new models of service delivery that will improve or sustain the level of care already provided.1 Canadians are open to a wide variety of initiatives to improve the health care system, and strongly support the notion that health research will contribute to the pace of innovation in health care and evidence-based decision-making.2
In order to forge an "integrated health research agenda across disciplines, sectors and regions that reflects the emerging health needs of Canadians and the evolution of the health system and supports health policy decision-making" (CIHR Act), CIHR and its Institutes have engaged, with a variety of partners, in consultations intended to elicit national priorities, and in a number of innovative research funding programs. Through partnerships with key stakeholders, CIHR is striving to support internationally competitive research initiatives that produce timely, high quality evidence with near term improving effects on the Canadian health care system and the health of Canadians. Partnerships are about shared vision, common objectives and alignment of priorities and programs. Partnerships are also critical to making more effectve use of resources for research and are key to any successful knowledge translation strategy. In keeping with that spirit of collaboration and common vision and objectives, this strategic funding initiative involves partnerships between researchers, users of research, and funders of research.
In early 2004 CIHR published Investing in Canada's Future: A Blueprint for Health Research and Innovation to articulate its vision, mandate and strategic directions for the coming years. One strategic direction is to "support health innovations that contribute to a more productive health system." The foundation for CIHR's Blueprint is the extensive work of its 13 institutes in developing their own strategic plans. Since 2001, CIHR's 13 institutes have conducted wide-ranging consultations to develop coordinated, focused and integrated health research agendas within their respective health research domains. This strategic funding initiative has been designed to provide operating grant funds to support applied health services, systems and policy research in thematic areas that have been identified as a priority by one or more of CIHR's 13 institutes.
Applied health services, systems and policy research has played an important role in discussions, debate and decision-making in health care in Canada for decades, and will continue to do so in the current 'evidence-based' environment. While decision-making in health care is a complex process, research evidence has an important role to play. When the research process is guided by the information needs of users of research, findings are more likely to be translated into new knowledge. Moreover, it is becoming increasingly evident that effective knowledge translation requires continuous long-term interaction between researchers and users of research. Therefore, this initiative requires meaningful collaboration between a researcher(s) and system decision-makers likely to be able to make use of the results of the research, and will involve merit review of proposals where researchers and decision-makers jointly assess potential impact of the research on the health system, as well as scientific merit.
In addition to financial support from CIHR3, this funding program relies heavily on the participation of partners and stakeholders to promote effective knowledge translation and to match CIHR's contributions (at least 1:1 matching is required). Applicants are invited to visit the Description of Partners to find information about Partners and their specific mandates, involvement and contributions. This list will continue to evolve as new Partners join this initiative.
There are three types of partnerships as part of this competition:
1) Decision-maker Partners
These are active participants or advisory bodies on specific projects of research and are identified on grant applications.
Letters of Intent and Full Applications must involve relevant decision-maker partners. (A decision-maker is an individual who makes decisions or influences policies that have a direct influence on the organization, delivery, financing, management, regulation or delivery of health systems or services.)
Decision-makers and decision-maker organizations are considered partners when active as members of the investigative team or when participating through a significant advisory mechanism. Proposals that do not include relevant decision-makers as investigators or as significant advisors are not eligible for funding. Decision-makers' participation on research projects is a concrete demonstration of the importance of the topic to them and their commitment to the regular sharing of issues and results related to the research. Their partnership indicates a commitment to developing an ongoing relationship with a group of researchers to help answer questions in their managerial or policy-making area.
Although it is desirable to have decision-maker partners who also contribute funds or in-kind contributions such as staff release time, in situations where this is not possible, one or more of the other partner types must be approached to meet the matched funding requirement.
2) Competition Partners
These are organizations that have agreed to provide funding support to this competition.
CIHR has negotiated competition partnerships with a number of health research funding agencies, Ministries or Departments of Health, and other stakeholders that have expressed an interest in supporting this competition. These commitments are generally restricted either to researchers from, or working on issues that are a priority for, a particular province, or to research on a particular theme. Although many competition partners only support researchers from their own province, they may also consider supporting other researchers with multi-jurisdictional projects.
To date, the following organizations and stakeholders have committed their support to the current competition: (For additional information on these competition partners, please see the Description of Partners).
The funding available from each of the competition partners is subject to revision without notice. Funding from competition partners may also be subject to confirmation that the proposed research fits within the partner's priorities.
Partnership arrangements with competition partners are negotiated directly between the applicant and the competition partner in question. Researchers and decision-makers interested in exploring such partnerships should communicate directly with the appropriate contact for each organization as indicated in the Description of Partners Researchers must also obtain a Letter of Support from the competition partner indicating their commitment to the project.
3) Project-specific Partners
Eligible applicants may obtain contributions (cash or in-kind) from other partners that they identify themselves and with whom they negotiate. Such partners could be universities, foundations, voluntary health charities, provider associations, other provincial government departments, or the private sector.
For private sector partners: please note, CIHR's financial contribution to a project is not to exceed that of private sector partner(s). The private sector consists of for-profit organizations, including companies, industry consortia, industry associations, and commodity or producer groups. Special circumstances may be considered on a case by case basis.
A list of such partners active in the first PHSI competition is provided as a reference in the Description of Partners. Where "decision-maker partners" also bring resources (cash or in-kind) to a project, they may also be considered project-specific partners.
The purpose of this funding opportunity is to support teams of researchers and decision-makers interested in conducting applied health services and policy research in theme areas identified below, that will be useful to health system managers and/or policy makers over the next two-to-five years. More specifically, this initiative is intended to:
Ten priority thematic areas emerged during a national consultation (Listening for Direction II) that was undertaken by CHSRF, CIHR - IHSPR, the Canadian Institute for Health Information, the Advisory Committee on Governance and Accountability of the Federal/Provincial/Territorial Conference of Deputy Ministers of Health, and the Health Statistics Division of Statistics Canada. All of these are eligible research areas for this competition. Detailed descriptions of, and sample research questions for, each of these themes can be found in the Listening for Direction II final report.
Workforce planning, training and regulation
Within these research areas, as appropriate, applications focused on particular populations such as: official language minority communities, informal/voluntary care givers, isolated populations (e.g., Aboriginal or northern communities) and vulnerable populations including ; immigrants, refugees, the disabled, the poor, the homeless, people with stigmatizing conditions, the elderly, children and youth in disadvantaged circumstances, people with poor literacy skills, and women in precarious circumstances are of particular interest.
A number of other partners have identified areas of focused interest to which they have committed targeted funding (see Description of Partners for further details).
These include an 11th theme and three sub-themes:
Nurses make up the largest healthcare provider group in the healthcare system. Staffing and other workplace issues remain critically important to this group. As well, a recent nursing consultation identified the need for further work on strategies that address generational differences, such as recruitment and retention issues related to work-life balance expectations; full-time employment opportunities; and specific education and mentoring needs that support the transition of new nurses into a complex work environment. There is also increasing evidence that nursing care has a large impact on quality of care and patient safety. Thus there is significant overlap between this theme and two of the other strategic themes: health human resources and managing for quality and patient safety. Proposals responding to these other themes can be within the scope of the nursing theme as long as they have a nursing health services focus.
Examples of issues that proposals could address include:
Integral to all of the above are strategies to implement models of innovation at a system level, including recommendations from CHSRF's report Commitment and Care [ PDF (511 KB) | Help ] published in 2001 and the final report of the Canadian Nursing Advisory Committee published in 2002.
The three sub-themes in the current competition are:
i) Mental health and the health care workplace (fits within the "Management of healthcare workplace" LfD II theme)
Eligible research questions under this topic focus on mental health and health care workplaces, and include health system decision-makers from human resources, other relevant departments, and/or a variety of agencies (e.g., institutions, health regions, provincial ministries). Research priorities include, but are not limited to: mental health promotion in health care workplaces, stigma and health care work, transforming knowledge into practice, and disability management and return to work.
In early 2004, CIHR's Institutes of Population and Public Health, and Neurosciences, Mental Health and Addictions sponsored a national workshop that focused on Mental Health in the Workplace. Please consult the full report from that workshop, for more information.
ii) Infections acquired in hospitals (fits within the "Managing for quality and safety" LfD II theme)
Infections that are acquired in acute, long term or continuing care facilities pose an important threat to patient health and safety. In addition to the financial cost, nosocomial infections add to functional disability, emotional stress and in some cases, lead to disabling conditions that reduce the quality of life or even result in death. There are important gaps in our knowledge about how infection in hospitalized patients can best be controlled or prevented.
Treatment of nosocomial infections frequently results in increased antibiotic use that in turn promotes antibiotic resistance. Increasingly more and more antibiotics are becoming ineffective against common pathogens, generating concern over our ability to control bacterial infections in the future. The large pharmaceutical companies that produced our current antibiotics have drastically cut back on the production of new drugs. Interventions and practices that prevent infection are important elements in strategies to reduce antibiotic use and preserve the usefulness of those antibiotics that are still effective. In March 2005, CIHR-Institute of Infection and Immunity (CIHR-III) hosted a workshop entitled "Novel Alternatives to Antibiotics" to discuss new ways to combat bacterial infections should antibiotics fail. One recommendation was to explore changes to the physical environment and the use of new biomaterials as mechanisms to prevent the onset of infections caused as a result of hospital practices and interventions such as surgery.
CIHR-III is interested in proposals that examine the effect of changes in physical systems and the use of new biomaterials in preventing infections acquired in acute, long term or continuing care facilities. Of particular interest is the potential for applying research findings directly to effect system - or institution - level changes to policies or procedures.This funding opportunity will promote partnerships between health care providers, decision makers and researchers from the physical/engineering and life sciences fields. Topics of particular interest include but are not limited to:
iii) Physical Activity, Mobility & Health (fits within the "Timely access to quality of care for all" LFDII theme)
CIHR-IMHA will support research across any of the six foci in its mandate:
Specifically IMHA is interested in research that addresses the "Timely access to quality of care for all" theme, as it relates to IMHA's physical activity, mobility and health research priority area.
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Applications in which the funding request from CIHR exceeds the maximum allowable amount are ineligible and will not be merit reviewed.
Randomized Controlled Trials (RCTs) designed to examine organization and system level interventions within eligible research areas will be considered for funding. Examples include RCTs of program or policy interventions designed to improve health care delivery or strengthen health care systems. RCTs designed to study clinical interventions are not eligible.
Applicants who are considering submitting an application containing an RCT in response to this Request for Applications are required to consult CIHR RCT staff listed in Contact Information and are advised to familiarize themselves with the RCT specific guidelines and instructions. Full applications containing an RCT will be reviewed by the Randomized Control Trial Committee and the PHSI Merit Review Committee, and must meet the threshold of excellence of both committees to be considered for funding. Applicants who include RCTs in their proposal will be provided with additional instructions to facilitate this parallel review.
Specific Eligibility Requirements
Eligibility requirements specific to this Request for Applications include the following:
Please note: In addition to standard CIHR applicant roles (i.e., Principal Applicant, and Co-applicant), two applicant roles have been added for this competition: Principal Decision-maker Applicant and Decision-maker Applicant, which are equivalent to Principal Applicant and Co-applicant respectively.
In addition to the standard CIHR eligibility requirements, the following special conditions apply:
Mechanism of Support
This competition is funded as an operating grants competition, and is designed to solicit project grant applications with a duration of up to 3 years.
Funds Available
Based on the total funds available for this program, applications will be funded from the top-ranked down as far as budgets will allow. Separate funding envelopes will be established for each CIHR and Competition Partner. Applications will be funded from the top-ranked down, within these envelopes, as far as these partners' budgets will allow. Applications receiving a score of less than 3.5 will not be considered for funding, even if this means that no work will be supported by one or more of the CIHR and Competition partners.
CIHR's financial contribution to a project is not to exceed that of private sector partner(s). The private sector consists of for-profit organizations, including companies, industry consortia, industry associations, and commodity or producer groups. Special circumstances may be considered on a case by case basis.
The full application must provide a detailed budget and justification of all costs. This justification must include direct costs that relate to the proposed knowledge translation activity outlined in the project description itself.
Grants should NOT be used:
Allowable costs for these project grants include:
Applicants should review Use of Grant Funds and Eligibility of Expenses, Employment under Grants within the General Guidelines for All Research Grants for a complete listing and description of allowable costs and activities.
The full application must provide a detailed justification of all costs.
Criteria for Merit Review
The following criteria will be used to evaluate both the letter of intent and invited full applications:
a) Potential Impact
Assessment criteria include:
b) Scientific Merit
Assessment criteria include:
Evaluation Process
Eligibility Screening
Letters of intent will be initially screened by CIHR staff in conjunction with members of a Merit Review Panel. Letters of Intent will first be screened for eligibility on the basis of the following factors:
Merit Review of LOI
Letters of intent deemed eligible will then be evaluated by a CIHR Merit Review Panel. The panel will be created specifically for this program. Committee members are selected based on suggestions from many sources including the Institute(s), partner(s) and the research community. Names of panel members are published on the CIHR web site. The committee will use the CIHR Merit Review Scale.
| Potential Impact | Scientific Merit | ||
| Fundable: | enormous extremely significant very significant |
4.5-4.9 4.0-4.4 3.5-3.9 |
outstanding excellent very good |
| Seldom funded: | significant | 3.0-3.4 | acceptable, but low priority |
| Not fundable: | moderate limited negligible |
2.5-2.9 2.0-2.4 0-1.9 |
needs revision needs major revision seriously flawed |
All letters of intent will be reviewed by at least one decision-maker and one researcher, who will assess potential impact and scientific merit, as well as the quality of the research team. Potential impact and scientific merit will be given equal weight in the assessment of the LOI by the merit review panel. The entire merit review panel will then determine the final ranking of each letter of intent. Only those letters of intent that receive a score of 3.5 or more on both potential impact and scientific merit will be considered for invitation to the full-scale application stage.
Relevance Review
Prior to merit review of the invited full applications, the appropriate Institute and/or Competition Partner representatives may first evaluate full applications for relevance in relation to their particular interests (for partnership purposes). As such, those representatives will have access to the anonymized project titles and full application summaries (page 9 of the Research Module).
Merit Review of the Full Application
Invited full applications will be evaluated by a CIHR Merit Review Panel. The panel will assess potential impact and scientific merit, as well as the quality of the research team. Only those full applications receiving a score of 3.5 or more on both potential impact and scientific merit will be considered for funding.
Upon completion of merit review, the participating CIHR Institutes and Competition partners will receive the anonymized ranking list, merit scores (ratings) and recommendations of the merit review committee with regards to funding level and award term, for the submitted applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative.
The review of applications for relevance to the strategic initiative will have no impact on the merit review process.
This Request for Applications will follow the General Guidelines for All Research Funding Grants.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
In addition to CIHR standard guidelines and requirements, the following special conditions shall apply to this competition:
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.
The KT Branch has made plans to assess performance of this initiative through ongoing monitoring and periodic evaluation. We are committed to informing Canadians about the performance of our initiatives and the results that they deliver.
The following table is intended to further clarify objectives by linking them to expected outcomes and measures. All funded applicants will be expected to participate in the evaluation strategy, contributing advice, data and reports as required for assessment purposes.
| Objective | Outcome | Measure/Indicator |
| Support research that "reflects the emerging health needs of Canadians and the evolution of the health system and supports health policy decision-making". | Funded research is identified as a high priority by health policy decision-makers. Funded research supports health policy decision-making. |
Active decision-maker involvement throughout the research project due to their perceptions of high priority theme. Decision-maker partners report that funded research supports health policy decision-making. Examples of policy decision-making based on research. |
| Support research relevant to decision-makers by producing results that can be applied to multiple regions and/or settings. | Applicability of results to multiple regions and/or settings. |
Decision-makers in other regions and/or settings who are not involved in the funded research report that the work supports health policy decision-making. Peer reviewed article addresses the applicability of the results to multiple regions and/or settings. |
| Foster "collaboration with the provinces and with individuals and organizations in or outside of Canada that have an interest in health or health research" and engage a variety of partners, "in or outside Canada, with complementary research interests". | Collaborations among a variety of researchers and decision-makers that are attributable to involvement in the funded research. | New collaborations among a variety of researchers and decision-makers, attributable to involvement in the funded research, that last throughout the term of the work. Collaborations among a variety of researchers and decision-makers, attributable to involvement in the funded research, that are sustained long after the term of the work. |
| Promote the involvement and recognition of, and respect for, health researchers from an array of health disciplines. | Multidisciplinary research teams. | The array of disciplinary backgrounds of research team members, and the extent to which these backgrounds are engaged to enhance the quality of the funded work. |
| Enable the dissemination of knowledge and application of health research to improve the health of Canadians and the strength of the Canadian health care system. | Improved linkages and exchanges among researchers and users of research. Created new knowledge and influenced decision-making in health care policy and practice. |
Number and nature of knowledge translation activities. Increased awareness among decision-makers about the research findings. Increased awareness among researchers about the research needs of decision-makers. Extent to which new knowledge has been created. Extent to which new knowledge has influenced decision making. |
There are two stages to the application process:
1) LOI; and,
2) Full Application.
To access CIHR web forms, all applicants and co-applicants (including Decision Maker applicants) must acquire Personal Identification Numbers (PIN). There will be a delay of approximately one working day to receive confirmation of a PIN. More than one working day may be required in peak periods - late January and early August. The PIN will also be needed to complete the Common CV for CIHR.
Applicants are advised to refer to the "Guidelines for Completion" specific to each application module, and the instructions on How to Apply for Funding, including the applicable section of the Grants and Awards Guide.
The following special instructions apply to this competition:
Applicants are required to use the CIHR Web Forms when applying for funding to all CIHR programs. PDF forms will not be accepted. However, the Partnership Module (for "Partnerships for Health System Improvement") has no web form equivalent and must be completed manually (inputted electronically) using the PDF form format.
1) Letter of Intent (LOI)
The team must submit one original and six copies of a Letter of Intent, which will be reviewed for responsiveness/thematic fit. Letters of Intent must be postmarked no later than December 15, 2005. The Letter of Intent is comprised of:
a) CIHR Research Module
The Research Module must be completed using the Webforms:
Please refer to "The Meaning of Signatures on Application Forms" and "Applicant Categories for CIHR Grants," in the CIHR Grants and Awards Guide.
b) Letter of Intent
The letter of intent itself must not exceed five pages including figures and tables and the Summary of Research Proposal (p. 9). Letters of Intent will be evaluated as per the evaluation criteria detailed in the Criteria for Merit Review section. Applicants are expected to use the headings below to organize the letter of intent:
Research: This section should describe: the objectives and question(s) to be addressed, based on an assessment of the existing literature and practice; the methods and approach to be employed; the importance and likely outcome of the research, the likely generalizability and validity of the results, and the research timeline. Please note that the methods and approach should be sufficiently well developed and clearly described so that it is possible for the merit review panel to assess feasibility and relevance.
Impact: This section should address questions such as the following: Are the "process" or "outcome" measures relevant and useful to a significant number of health-system managers and policy makers? How will the research results be used in the planning, allocation, or management decisions of policy makers? Can the research results be applied? Are they applicable outside a single region or institution? Are appropriate numbers of the decision-maker audience active in the proposal? Will this audience still be interested in the results when they are available? Will the dissemination of the research results respect the ways in which decision-makers are likely to acquire and apply information? Has the communication plan been informed by decision-maker preferences?
Investigative team: This section should include the names and affiliations of the investigative team members, with a brief statement of their roles (e.g., researcher, decision-maker), experience, area(s) of expertise, time commitment and planned contributions to the project. It should also include a brief description of the structures and processes in place (or that will be put in place) to encourage the regular collaborative planning, resolution of issues, and sharing of results between members of the investigative team.
Knowledge Translation Plan: This section should include the identification of the audience(s) the research is relevant to, and a description of the approaches that will be taken to reach the audience(s). Applicants should describe plans for linkage and exchange activities, and outline how these approaches will increase potential use/broader application of results. Applicants should indicate whether there are plans to informally evaluate the effectiveness of the chosen approach to knowledge translation. The more sensitive the plan is to the preferences of the relevant managers and/or policy makers, the higher it will be rated.
Budget: This section should include:
c) Attachments
The general presentation guidelines for completing CIHR application forms must be followed, e.g., use single-spaced type NO smaller than 12 point. These guidelines are available on the CIHR web site.
2) Full Application
All invited teams must submit one original and eight copies of the full application. Full applications must be postmarked no later than May 1, 2006.
The Full Application is comprised of:
a) Covering Letter
The cover letter should identify the name of this funding initiative (i.e., Partnerships for Health System Improvement), and the name of the decision-maker partner's organization. The name of a contact person within this partner organization should be provided, as well as his/her contact information. The letter should also state which of the 11 eligible thematic areas the proposal primarily addresses and any sub-themes, if applicable.
b) The CIHR Operating Grants application package
When completing the CIHR Operating Grants application package, please note the following information:
In the Research Module:
In the CIHR Operating Budget Module:
In the Common CV (for CIHR):
c) The Partnership Module [ PDF (106 KB) | Help ]
d) Attachments
Consider the following TIPS and TRAPS when you are applying:
Send Application by Courier to:
RE: "Partnerships for Health System Improvement"
Canadian Institutes of Health Research
Research Portfolio
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, Ontario K1A 0W9
Contacts for Further Information:
For questions on CIHR funding guidelines, how to apply and details about the merit review process, please contact:
Marilyn Desrosiers (Updated: 2006-02-16)
Program Delivery Officer
Canadian Institutes of Health Research
Telephone: (613) 941-4439
Fax: (613) 954-1800
Email: mdesrosiers@cihr-irsc.gc.ca
For questions regarding Randomized Control Trials, please contact:
Irwin Schweitzer
Trials Officer (RCT program)
Canadian Institutes of Health Research
Telephone: (613) 941-0718
Fax: (613) 954-1800
Email: ischweitzer@cihr-irsc.gc.ca
Note: Additional partners may join this funding initiative over the coming year.
Sources of CIHR Support
Applicants are not required to contact the individual CIHR Institutes, Branches, Programs or Initiatives described below to secure funding from CIHR.
Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
In addition to the strategic funding identified below, an allocation of $500,000 is available to researchers undertaking projects of research in the provinces of Newfoundland, Nova Scotia, New Brunswick, Prince Edward Island, Manitoba and Saskatchewan. This provincial partnership initiative is intended to expand the pool of available funds and thereby increase health research activity in these provinces. Researchers in the provinces identified above will be required to secure only 1/3 of the total cost of the project (e.g., up to $100,000 out of $300,000 over the life of the project) from their partners.
CIHR - Institute of Aboriginal Peoples' Health (IAPH)
IAPH supports research to address the special health needs of Canada's Aboriginal people.
Depending on available funds, through this competition the CIHR-IAPH will support research in all themes and sub-themes that contributes to the improvement of the health and well-being of First Nations, Inuit and/or Métis people. It will support innovative research projects that generate new knowledge based on scientific excellence, cultural relevance and community collaboration. Applicants should also build partnerships and alliances between aboriginal communities and relevant health research organizations/institutes at the local, regional and/or national levels.
CIHR - Institute of Aging (IA)
IA supports research to promote healthy aging and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with aging. IA has identified five priority areas for research on aging and health (in no particular order): healthy and successful aging; biological mechanisms of aging; cognitive impairment in aging; aging and maintenance of functional autonomy; and health services and policy relating to older people.
IA will contribute up to $200,000 per year to successful applications that fit within one or more of its priority research areas, with emphasis on the area of mobility in aging in the context of the aging and maintenance of functional autonomy priority.
CIHR - Institute of Cancer Research (ICR)
ICR fosters research based on internationally accepted standards of excellence, which bear on preventing and treating cancer and improving the health and quality of life of those living with the disease.
In response to increasing public concerns about access to health care services and programs ICR has identified a new strategic research priority 'Access to Quality Cancer Care'. A planning workshop on this topic resulted in the identification of specific areas of concern for cancer that would best be addressed by a multi-faceted research response. Applicants are encouraged to read the full workshop report [ PDF (1.7 MB) | Help ].
ICR will contribute up to $200,000 per year to successful applications in the thematic area of "Timely Access to Quality Care for All"
ICR is interested in research across the entire spectrum of cancer control from prevention to palliation that will lead to improvements in access to quality cancer care. Topics might include but are not limited to:
Health Services and Organizational Aspects of Access to Quality Cancer Care
Ethical Funding and Resource Allocation
Enhancing Information Systems
CIHR- Institute of Circulatory and Respiratory Health (ICRH)
ICRH supports research into the causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood vessels, blood, [critical care, and sleep].
CIHR-ICRH encourages researchers from the circulatory-respiratory community to participate in this research initiative and will consider providing funding to highly ranked applications of relevance to ICRH's mandate.
CIHR - Institute of Gender and Health (IGH)
IGH supports research that addresses how sex (biological-genetic dimensions) and gender (social-cultural dimensions) interact with other socio-cultural, bio-physical, and political-economic factors to influence health and create conditions that differ with respect to risk factors or effective interventions for males and females throughout the lifespan. The objectives of the Institute for Gender and Health are to (1) generate evidence regarding the impact of sex and gender on health status, health behaviour, and health services use throughout the life span; (2) enhance understanding of how gender, sex and health interact with other health determinants; (3) provide evidence to inform the design of programs, policies and practices; (4) build the capacity of gender and health researchers in Canada; and (5) advance the gender and health perspective nationally and internationally.
IGH's maximum contribution to this initiative will be $100,000 per annum for three years. IGH will support successful applications in all research theme and sub-theme areas that are relevant to its mandate and any of the following research priorities:
The Institute of Gender and Health strongly encourages applicants to demonstrate the use of sex/gender-based or sex/gender-sensitive analysis (SGBA) in applications. SGBA is an approach to research and evaluation which systematically inquires about biological (sex-based) and sociocultural (gender-based) differences between women and men, boys and girls, without presuming that any such differences exist. The purpose of SGBA is to promote rigorous sex/gender-sensitive health research which expands understanding of health determination in both sexes, in order to provide knowledge which can result in improvements in health and health care. IGH is currently examining various ways to stimulate substantive SGBA practice among the research community. In the meantime, we refer you to the Canadian resource on SGBA policy and practice published by Health Canada which can be found at the web addresses below.
* Please note that if you locate and/or use alternate sex and gender sensitive guidelines, we would appreciate their citation.
CIHR - Institute of Genetics (IG)
IG supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.
Depending on available funds, the CIHR-IG will support applications - relevant to its mandate - in all research themes and sub-themes.
CIHR - Institute of Health Services and Policy Research (IHSPR)
IHSPR supports outstanding research, capacity-building and knowledge translation initiatives designed to improve the way health care services are organized, regulated, managed, financed, paid for, used and delivered, in the interest of improving the health and quality of life of all Canadians.
IHSPR has committed up to $1,000,000 per year to this competition available to applicants working in areas identified as priorities in the recent LFDII priority setting-process.
CIHR - Institute of Human Development, Child and Youth Health (IHDCYH)
IHDCYH supports research that ensures the best start in life for all Canadians and the achievement of their potential for optimal growth and development. Through our support, researchers address a wide range of health concerns, including those associated with reproduction, early development, childhood, and adolescence.
Depending on available funds, through this competition the CIHR-ICRH will support research in all research themes and sub-themes.
CIHR - Institute of Infection and Immunity (III)
III seeks to establish national leadership, priorities and programs that promote innovative research to reduce the global burden of infection and immune-based disease and improve quality of life.
III will contribute up to $150,000 per year to successful applications in the thematic area of "Managing for quality and safety" within the 'Infections Acquired in Hospitals' sub-theme. As part of an integrated research initiative on "novel alternatives to antibiotics" and in response to recommendations from a workshop held on this subject, III is specifically interested in research on the role of the physical environment and the use of novel biomaterials in reducing hospital acquired infections and the need for antibiotics. Applicants are advised to consult the full workshop report [ PDF (1.8 MB) | Help ].
Eligible topics might include but are not limited to:
Applications from multidisciplinary research teams that include a health care provider, decision maker and researchers from the physical/engineering and life sciences fields are strongly encouraged.
CIHR - III -HIV/AIDS Research Initiative
The Institute of Infection and Immunity also manages the HIV/AIDS Research Initiative, a component of the Federal Initiative to Address HIV/AIDS in Canada. The Federal Initiative to Address HIV/AIDS in Canada (FI-HIV/AIDS) reaffirms the Government of Canada's commitment to fight the HIV/AIDS epidemic both in Canada and globally and has as one its goals to improve the quality of life of those infected with the disease. Evaluations and other consultative exercises have highlighted the need for the federal government to develop approaches to addressing the epidemic for people living with HIV/AIDS, gay men, injection drug users, Aboriginal people, prison inmates, youth and women at risk for HIV infection, and people from countries where HIV is endemic.
III-HIV/AIDS Research Initiative will contribute up to $200,000 per year applications falling under the LFDII theme area "Timely access to quality care for all" particularly as it applies to improving access for vulnerable groups. Specifically, the III-HIV/AIDS Research Initiative is interested in research which provides data and information to:
CIHR - Institute of Musculoskeletal Health and Arthritis (IMHA)
IMHA support research to sustain health and enhance quality of life by eradicating the pain, suffering and disability caused by arthritis, musculoskeletal, oral and skin conditions.
IMHA will contribute up to $100,000 per year to support research that addresses the "Timely access to quality of care" theme, as it relates to IMHA's physical activity, mobility and health research priority area.
CIHR - Institute of Neurosciences, Mental Health and Addiction (INMHA)
INMHA supports research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.
Depending on available funds, through this competition the CIHR-INMHA will support research within the sub-theme area i) Mental Health and the Workplace, which fits within the theme Management of healthcare workplace.
CIHR - Institute of Nutrition, Metabolism and Diabetes (INMD)
INMD following an extensive environmental scan and stakeholder input [ PDF (510 KB) | Help ] identified 'Obesity and Healthy Body Weight' as its focus for strategic research funding. To effectively reverse this epidemic it is imperative that research generate new knowledge on the multiple and interacting causes of obesity, on best practices for its prevention in both individuals and populations, and on cost-effective and ethical measures for treatment. For more information about INMD's strategic priority visit the Excellence Innovation and Advancement in the Study of Obesity and Healthy Body Weight.
Depending on available funds, through this competition CIHR-INMD will support research in all research themes and sub-themes, which have are relevant to issues related to the measures, causes, prevention, treatment or consequences of obesity.
CIHR - Knowledge Translation Branch (KT)
An important part of CIHR's mandate is to translate knowledge into improved health for Canadians. In responding to this broad mandate, it will be necessary for CIHR to strengthen relationships among health researchers and users of health knowledge, enhance capacity for knowledge uptake, and accelerate the flow of knowledge into beneficial health applications.
The KT Branch will contribute up to $500,000 per year to applications which will strengthen relationships among health researchers and users of health knowledge for effective knowledge translation that will lead to improved health for Canadians, more effective services and products and a strengthened Canadian health care system.
CIHR - Innovation and Industry Programs (IIP)
CIHR's Innovation and Industry Programs are designed to help the academic community interact with Canadian companies with an interest in health research and development. The programs promote a wide variety of peer-review research and training projects jointly funded by Canadian companies and CIHR. The research planned should be beneficial to both parties, while improving the quality of health of Canadians.
Depending on available funds, through this competition the CIHR-IIP will support research in all research themes and sub-themes, where applicant teams secure the required matching funds (cash or in-kind) from public (other than federal government), not-for-profit, or private sector sources.
Note that CIHR's financial contribution to a project under this competition cannot exceed that of any private sector partner(s). For this purpose, the private sector is meant to include for-profit organizations, including companies, industry consortia, industry associations, and commodity or producer groups with the ability to further develop and/or exploit benefits of research.
Partnership and support is being negotiated with a number of other health research funding organizations. These commitments are generally restricted to either researchers from or working on the issues related to a particular province, or research on a particular theme. Although many provincial partners will only support researchers from their own province, consideration may also be given to multi-jurisdictional projects.
In all cases commitment is subject to availability of appropriated funds in the budgets of each party. The funding ceilings are subject to revision without notice and are also subject to their confirmation that the proposed research fits within their priorities and regulations. Each applicant is responsible for contacting the appropriate competition partner to solicit a Letter of Support for the Letter of Intent stage of the competition. Further information on the format can be found by clicking on Letter of Support.
Researchers undertaking projects of research in the provinces of Newfoundland, Nova Scotia, Prince Edward Island, Manitoba and Saskatchewan will only be required to get financial commitment from their respective provinces for 1/3 of the total cost of the project or up to $100,000.
Canadian Health Services Research Foundation/Nursing Research Fund
Up to $200,000 is available for successful projects in this CIHR competition (maximum of $100, 000 per project), submitted under the nursing leadership, organization and policy theme. Applicants can continue to access other NRF funds made available through the CHSRF through the Research Exchange, and Impact for System Support (REISS) Competition. Funds will be allocated according to the merit review panel ratings as funds are available. Applicants under this theme may also wish to identify other potential partners in case there are insufficient funds from the Nursing Research Fund to support all the meritorious proposals approved under this theme.
Please note that applicants seeking CHSRF support need to send a copy of their LOI and Full Application to CHSRF.
For further information contact:
Joanne Casey
Grants and Awards Management Coordinator
Canadian Health Services Research Foundation
Tel: (613) 728-2238 ext. 218
Fax: (613) 728-3527
E-mail: joanne.casey@chsrf.ca
Web site: http://www.chsrf.ca/
Alberta Heritage Foundation for Medical Research (AHFMR)
AHFMR supports a community of researchers who generate knowledge whose application improves the health and quality of life of Albertans and people throughout the world. The long-term commitment is to fund health research based on international standards of excellence and carried out by new and established investigators and researchers in training.
Funding is available for successful projects in all themes through the AHFMR Opportunity Fund. AHFMR will not usually contribute more than $100,000 per project or 50 percent of total costs, whichever is less. AHFMR's total contribution through the fund will not normally exceed $500,000 per year. Funding is usually reserved for Alberta-based researchers and decision-makers.
For further information see the AHFMR web site or contact:
Mr. Mark Taylor
Director, Grants & Awards
Alberta Heritage Foundation for Medical Research
Tel.: (780) 423-5727
Fax: (780) 429-3509
E-mail: mark.taylor@ahfmr.ab.ca
Fonds de la recherche en santé du Québec et Ministère de la Santé et des Services sociaux du Québec
In this competition, funding is available for successful projects at an amount equivalent to 40 percent of the annual budget. For projects, the maximum contribution is $80,000 over the duration of the project. Applications will be funded based on available funds. Applicants must obtain the remaining 10 percent from another source. Note that as for other FRSQ operating grant's programs, priority will be given to applications originating from new investigators, i.e. from investigators that would normally be eligible for a Junior 1 FRSQ Chercheur Boursier award (8 years or less after last degree). However, in compliance with CIHR guidelines, applications from senior investigators will also be considered.
Letters of intent should be submitted simultaneously to the FRSQ and to CIHR by the December 15 deadline. Funding is for Quebec researchers and decision makers only. For further information visit the FRSQ web site or contact:
Mme Ginette Piché
Directrice des programmes
Fonds de la recherche en santé du Québec
Tel. (514) 873-2114, poste 241
E-mail: gpiche@frsq.gouv.qc.ca
M. Claude Dussault
Directeur de l'évaluation, de la recherche et de l'innovation
Ministère de la Santé et des Services sociaux
Tel. (418) 266-7025
E-mail: claude.dussault@msss.gouv.qc.ca
Government of Saskatchewan
Saskatchewan will fund applications in all themes and sub-themes depending on availability of funds through the Innovation and Science Fund established by the Saskatchewan government. Funds are usually reserved for Saskatchewan-based researchers and decision-makers.
Mr. Kevin Veitenheimer
Saskatchewan Learning
Tel.: (306) 787-7974
E-mail: kveitenheimer@sasked.gov.sk.ca
Manitoba Health
Manitoba Health has up to $25,000 per year available for successful new applications. In the event that there are more successful applications than available funds, applications will be funded based on the priority rating established by the CIHR merit review panel, until the fund is expended. Please note that this competition is administered by CIHR. All queries regarding the application process should be directed there, not to Manitoba Health.
For further information regarding specific requirements visit the Manitoba Health web site or contact:
Mr. Louis Barre
Manitoba Health
Tel.: (204) 786-7149
E-mail: lbarre@gov.mb.ca
Medical Research Fund of New Brunswick
The purpose of the Medical Research Fund of New Brunswick is to provide financial assistance for health-related research within the province. Depending on available funds, through this competition the Medical Research Fund of New Brunswick will support research in all research themes and sub-themes. Please note that this funding is only available to researchers based in New Brunswick.
For further information consult the Medical Research Fund of New Brunswick web site or contact:
Mr. John Boyne
Administrator
Medical Research Fund of New Brunswick
Tel.: (506) 444-3222
E-mail: john.boyne@gnb.ca
Michael Smith Foundation for Health Research (Updated: 2006-04-24)
The Michael Smith Foundation for Health Research (MSFHR) leads, partners and serves as a catalyst to build British Columbia's capacity for excellence in clinical, biomedical, health services and population health research. Through a grant from the BC Ministry of Health, the Foundation facilitated the development and supports the operations of a provincial Health Services and Policy Research Support Network (HSPRSN) to advance health services and policy research activity and capacity in the Province.
The HSPRSN recommended and MSFHR has approved use of HSPRSN funds to partner with the CIHR Institute of Health Services & Policy Research in the 2005 Partnerships for Health System Improvement Operating Grants competition. The following restrictions will apply:
Please note that these funds would be administered by, and all inquiries should be directed to, CIHR, and not to the HSPRSN or MSFHR.
Patricia Coward, RN, PhD
Executive Director
Health Services & Policy Research Support Network
c/o Michael Smith Foundation for Health Research
Telephone: (604) 714-6606
Email: pcoward@msfhr.org
Newfoundland and Labrador Centre for Applied Health Research (NLCAHR)
The Newfoundland and Labrador Centre for Applied Health Research has a mandate to increase the capacity of the province of Newfoundland to carry out high-quality research on applied health issues (by which is meant all health matters with a relevance to public policy and clinical decision-making).
NLCAHR has up to $30,000 per year available for successful new applications. Only projects involving a principal investigator who is a researcher or a decision maker based in Newfoundland and Labrador are eligible for funds. In the event that there are more successful applications than available funds, applications will be funded based on the priority rating established by the CIHR merit review panel, until the funds are expended. For further information, visit the NLCAHR web site or contact:
Stephen Bornstein
Director
Newfoundland and Labrador Centre for Applied Health Research
Tel.: (709) 777-6768
E-mail: sbornste@mun.ca
Nova Scotia Health Research Foundation
The mission of the Nova Scotia Health Research Foundation is to help improve the health of Nova Scotians by developing and supporting a vibrant and sustainable health research community throughout the province.
NSHRF is pleased to provide opportunities for matching grants. The maximum funding available for these grants is $100,000 ($50,000 a year for two years). Researchers interested in being considered for matching grants must submit a detailed letter of request to NSHRF with a copy of their letter of intent. Priority is based on funding availability and the demonstrated relevance to health research priorities of Nova Scotians.
Matching funds are available for successful projects of research under the PHSI. In the event that there are more successful applications than available funds, applications will be funded based on the priority rating established by the CIHR merit review panel, until the fund is expended.
Funding is for projects of research in which Nova Scotia researchers and decision makers figure prominently. To be eligible for matching funds from NSHRF for the PHSI competition, applicants must pre-register with the NSHRF by submitting their letter of intent in advance. Requests to NSHRF should be made not less than 2 weeks before the CIHR deadline- by November 17, 2005. Prior approval from NSHRF is required to be considered eligible for NSHRF matching funds. A letter of support will be provided by NSHRF if the application meets the NSHRF requirements.
For further information, visit the NSHRF web site.
Ms. Lesley Poirier
Program Manager Research Awards
Nova Scotia Health Research Foundation
Tel.: (902) 424-4043
E-mail: poiriell@gov.ns.ca
Please direct any requests for Matching Funds to NSHRF c/o Program Manager, Research Awards.
Ontario Ministry of Health and Long-Term Care
The Ontario Ministry of Health and Long-Term Care (MOHLTC) will consider co-funding applicants to the Partnership for Health System Improvement (PHSI) competition who undertake research projects aligned with the ministry's key priorities to achieve better health in Ontario and who receive a CIHR merit review score greater than 3.5.
Funding through the MOHLTC's Research Unit is for Ontario researchers and decision makers only but consideration may be given to multi-jurisdictional projects where at least one principal investigator resides in Ontario and where the outcome of the research is determined to be of direct benefit to MOHLTC. Please note that funds will be administered by CIHR.
Matching funds are available to a maximum of $0.1M per project. In the event that there are more successful applications than available funds, applications will be funded based on the priority rating established by CIHR's merit review panel, until funds are expended.
Transforming Health Care in Ontario
To deliver better health care, fundamental changes to the health care system are required. In order to achieve this goal we must re-establish a health care system in Ontario that is patient-focused, results-driven, integrated and sustainable. The plan for transforming the system is complex, but is anchored on a clear vision for health care in Ontario - healthy Ontarians in a healthier Ontario.
MOHLTC key priorities
Eligibility for MOHLTC Co-Funding
Prior approval from the MOHLTC's Research Unit is required to be eligible for consideration for matching funds. To secure prior approval, applicants must submit a copy of their letter of intent to the MOHLTC's Research Unit by November 15, 2005. (Updated: 2005-11-07)
Submit the Letter of Intent package by mail or fax to:
Attention:
CIHR PHSI Competition care of Research Unit
Knowlege Management and Reporting Branch
Ministry of Health and Long Term Care
101 Bloor Street
Toronto, Ontario M5S 2Z7
Fax: 416-327-1721
A ministry panel will review the projects. Projects that are most closely aligned with the ministry's key priorities will be of greatest interest and will receive a funding approval statement from the MOHLTC's Research Unit. The approval statement will indicate that the Research Unit has approved the use of MOHLTC funds for the project, should it achieve a CIHR merit review score higher than 3.5 and funds are available.
Approval statements will be faxed to applicants by December 1, 2005 for inclusion in the final package. These faxed agreement statements from MOHLTC will be accepted by CIHR as proof of support.
Applicants who are successful at the LOI stage will be notified by CIHR by February 15, 2006, and will be contacted by the MOHLTC's Research Unit to assemble additional materials for the full application.
Please note: the Letter of Intent requires contact information for a decision-maker partner. To be eligible for funding through the MOHLTC Research Unit, the decision-maker partner must represent a program/policy area within the MOHLTC. An MOHLTC decision-maker partner is necessary but not sufficient to secure funding approval from the MOHLTC's Research Unit. The Research Unit reserves the right to review proposals for alignment with MOHLTC research priorities and to approve funding eligibility. The Research Unit will not be a MOHLTC decision-maker partner.
For additional information regarding MOHLTC co-funding for this competition, contact:
Kelly Murphy
Research Transfer Advisor
Research Unit
Knowledge Management and Reporting Branch
Ministry of Health and Long-Term Care
Tel.: (416) 327-8364
Fax: (416) 327-7948
E-mail: kelly.murphy@moh.gov.on.ca
Prince Edward Island Health Research Program
The PEI Health Research Program was established to support and enhance research capacity while increasing our understanding of health in Prince Edward Island. The Program provides some financial support to allow researchers to access other sources of funding. The purpose of the Health Research Program is to provide new information regarding health services and systems in PEI; to conduct research aimed at providing new knowledge regarding PEI residents with diabetes, asthma, cancer, and other major illnesses; to provide new knowledge about the prevention, early detection and management of diabetes, asthma, cancer or other illnesses, and to assist in determining best practices in the prevention and treatment of diabetes, asthma, cancer or other illnesses.
Matching funds are available for successful projects of research under the PHSI. In the event that there are more successful applications than available funds, applications will be funded based on the priority rating established by the CIHR merit review panel, until the fund is expended. Only projects involving a principal investigator who is a researcher or a decision maker based in Prince Edward Island are eligible for funds.
Please note that this competition is administered by CIHR and all queries should be directed there. For further information, visit the PEI Health Research Program web site.
Project-specific Partners/ Decision-maker Partners
Applicants may also approach other organizations when seeking sources for matching funds. A list of such partners active in the first PHSI competition is available.
Please note: CIHR's financial contribution to a project is not to exceed that of any private sector partner(s). The private sector consists of for-profit organizations, including companies, industry consortia, industry associations, and commodity or producer groups. Special circumstances may be considered on a case by case basis.
|
List of Partners |
Type of Contribution (cash or in-kind) |
Year 1 |
Year 2 |
Year 3 |
TOTAL |
| CIHR | cash | $33,333 | $33,333 | $33,333 | $99,999 |
| CHSRF | cash | $33,333 | $33,333 | $33,333 | $99,999 |
| Ontario Community Support Association | In-Kind | $5,000 | $5,000 | $5,000 | $15,000 |
| St. Michael's Hospital | In-Kind | $10,000 | $10,000 | $10,000 | $30,000 |
| St. Michael's Hospital | cash | $5,000 | $5,000 | $5,000 | $15,000 |
Note: Amounts listed on this table must match amounts listed on the individual Partnership Modules and the CIHR Budget Module. Any discrepancies should be clearly explained.
1 Health Care in Canada Survey: Retrospective 1998-2003 [ PDF (228 KB) | Help ]. 2003. Pollara Research. Accessed August 10, 2004.
2 Health Care in Canada Survey [ PDF (510 Ko) | Help ]. 2003. Pollara Research. Accessed July 6, 2004.
3 CIHR support for the current competition Partnership for Health System Improvement (PHSI) comes from (at time of posting):
Institute of Aboriginal Peoples' Health (IAPH)
Institute of Aging (IA)
Institute of Cancer Research (ICR)
Institute of Circulatory and Respiratory Health (ICRH)
Institute of Gender and Health (IGH)
Institute of Genetics (IG)
Institute of Health Services and Policy Research (IHSPR)
Institute of Human Development and Child and Youth Health (IHDCYH)
Institute of Infection and Immunity (III)
Institute of Musculoskeletal Health and Arthritis (IMHA)
Institute of Neurosciences, Mental Health and Addiction (INMHA)
Institute of Nutrition, Metabolism and Diabetes (INMD)
Knowledge Translation Branch
Innovation and Industry Programs
4 The Objectives for the current competition refer to: Statutes of Canada 2000 Chapter 6 Bill C-13. "Act to establish the Canadian Institutes of Health Research" 13, April 2000.
